CAMTEK LTD (CAMT) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:CAMT • IL0010952641

141.11 USD
+8.36 (+6.3%)
At close: Feb 5, 2026
141.34 USD
+0.23 (+0.16%)
Pre-Market: 2/6/2026, 4:49:19 AM
Fundamental Rating

6

Taking everything into account, CAMT scores 6 out of 10 in our fundamental rating. CAMT was compared to 113 industry peers in the Semiconductors & Semiconductor Equipment industry. CAMT scores excellent on profitability, but there are some minor concerns on its financial health. CAMT is valued quite expensively, but it does show have an excellent growth rating. With these ratings, CAMT could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year CAMT was profitable.
  • In the past 5 years CAMT has always been profitable.
  • Each year in the past 5 years CAMT had a positive operating cash flow.
CAMT Yearly Net Income VS EBIT VS OCF VS FCFCAMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 13.72%, CAMT belongs to the top of the industry, outperforming 85.84% of the companies in the same industry.
  • With an excellent Return On Equity value of 21.36%, CAMT belongs to the best of the industry, outperforming 88.50% of the companies in the same industry.
  • CAMT's Return On Invested Capital of 13.47% is amongst the best of the industry. CAMT outperforms 86.73% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CAMT is in line with the industry average of 10.71%.
  • The last Return On Invested Capital (13.47%) for CAMT is above the 3 year average (11.43%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.72%
ROE 21.36%
ROIC 13.47%
ROA(3y)11.71%
ROA(5y)10.6%
ROE(3y)19.67%
ROE(5y)17.82%
ROIC(3y)11.43%
ROIC(5y)11.2%
CAMT Yearly ROA, ROE, ROICCAMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • CAMT's Profit Margin of 28.38% is amongst the best of the industry. CAMT outperforms 87.61% of its industry peers.
  • In the last couple of years the Profit Margin of CAMT has grown nicely.
  • CAMT has a Operating Margin of 26.86%. This is amongst the best in the industry. CAMT outperforms 84.96% of its industry peers.
  • CAMT's Operating Margin has improved in the last couple of years.
  • CAMT's Gross Margin of 50.46% is fine compared to the rest of the industry. CAMT outperforms 63.72% of its industry peers.
  • CAMT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.86%
PM (TTM) 28.38%
GM 50.46%
OM growth 3Y-0.13%
OM growth 5Y9.82%
PM growth 3Y7.46%
PM growth 5Y11.08%
GM growth 3Y-0.69%
GM growth 5Y0.63%
CAMT Yearly Profit, Operating, Gross MarginsCAMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • CAMT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for CAMT has been increased compared to 1 year ago.
  • Compared to 5 years ago, CAMT has more shares outstanding
  • CAMT has a better debt/assets ratio than last year.
CAMT Yearly Shares OutstandingCAMT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CAMT Yearly Total Debt VS Total AssetsCAMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 13.33 indicates that CAMT is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 13.33, CAMT belongs to the top of the industry, outperforming 81.42% of the companies in the same industry.
  • CAMT has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
  • CAMT has a Debt to Equity ratio of 0.32. This is in the lower half of the industry: CAMT underperforms 61.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z 13.33
ROIC/WACC1.12
WACC12.07%
CAMT Yearly LT Debt VS Equity VS FCFCAMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • CAMT has a Current Ratio of 5.41. This indicates that CAMT is financially healthy and has no problem in meeting its short term obligations.
  • CAMT has a Current ratio of 5.41. This is in the better half of the industry: CAMT outperforms 76.99% of its industry peers.
  • CAMT has a Quick Ratio of 4.38. This indicates that CAMT is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 4.38, CAMT is doing good in the industry, outperforming 76.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.41
Quick Ratio 4.38
CAMT Yearly Current Assets VS Current LiabilitesCAMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 21.46% over the past year.
  • CAMT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 34.86% yearly.
  • CAMT shows a strong growth in Revenue. In the last year, the Revenue has grown by 36.03%.
  • CAMT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.20% yearly.
EPS 1Y (TTM)21.46%
EPS 3Y20.9%
EPS 5Y34.86%
EPS Q2Q%9.33%
Revenue 1Y (TTM)36.03%
Revenue growth 3Y16.74%
Revenue growth 5Y26.2%
Sales Q2Q%12.15%

3.2 Future

  • Based on estimates for the next years, CAMT will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.67% on average per year.
  • CAMT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.74% yearly.
EPS Next Y16.26%
EPS Next 2Y9.9%
EPS Next 3Y11.97%
EPS Next 5Y15.67%
Revenue Next Year15.95%
Revenue Next 2Y10.92%
Revenue Next 3Y12.13%
Revenue Next 5Y15.74%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CAMT Yearly Revenue VS EstimatesCAMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M
CAMT Yearly EPS VS EstimatesCAMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 44.51 indicates a quite expensive valuation of CAMT.
  • Compared to the rest of the industry, the Price/Earnings ratio of CAMT indicates a somewhat cheap valuation: CAMT is cheaper than 66.37% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.67, CAMT is valued quite expensively.
  • CAMT is valuated quite expensively with a Price/Forward Earnings ratio of 41.57.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CAMT is on the same level as its industry peers.
  • CAMT is valuated expensively when we compare the Price/Forward Earnings ratio to 27.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 44.51
Fwd PE 41.57
CAMT Price Earnings VS Forward Price EarningsCAMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CAMT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 48.38
CAMT Per share dataCAMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CAMT does not grow enough to justify the current Price/Earnings ratio.
  • CAMT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.74
PEG (5Y)1.28
EPS Next 2Y9.9%
EPS Next 3Y11.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • CAMT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CAMTEK LTD

NASDAQ:CAMT (2/5/2026, 8:12:41 PM)

Premarket: 141.34 +0.23 (+0.16%)

141.11

+8.36 (+6.3%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-10
Earnings (Next)02-25
Inst Owners56.76%
Inst Owner Change-1.23%
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap6.46B
Revenue(TTM)429.00M
Net Income(TTM)133.74M
Analysts82.22
Price Target132.51 (-6.09%)
Short Float %12.16%
Short Ratio7.03
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.33
Dividend Growth(5Y)56.87%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.87%
Min EPS beat(2)-2.25%
Max EPS beat(2)0.51%
EPS beat(4)3
Avg EPS beat(4)1.36%
Min EPS beat(4)-2.25%
Max EPS beat(4)6.06%
EPS beat(8)7
Avg EPS beat(8)2.75%
EPS beat(12)10
Avg EPS beat(12)2.39%
EPS beat(16)12
Avg EPS beat(16)2.23%
Revenue beat(2)0
Avg Revenue beat(2)-1.43%
Min Revenue beat(2)-2.27%
Max Revenue beat(2)-0.59%
Revenue beat(4)1
Avg Revenue beat(4)-0.4%
Min Revenue beat(4)-2.27%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.3%
Revenue beat(12)2
Avg Revenue beat(12)-0.68%
Revenue beat(16)3
Avg Revenue beat(16)-0.74%
PT rev (1m)3.18%
PT rev (3m)10.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.12%
EPS NY rev (1m)0%
EPS NY rev (3m)0.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.37%
Valuation
Industry RankSector Rank
PE 44.51
Fwd PE 41.57
P/S 13.7
P/FCF N/A
P/OCF N/A
P/B 10.3
P/tB 11.94
EV/EBITDA 48.38
EPS(TTM)3.17
EY2.25%
EPS(NY)3.39
Fwd EY2.41%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.3
BVpS13.7
TBVpS11.82
PEG (NY)2.74
PEG (5Y)1.28
Graham Number31.26
Profitability
Industry RankSector Rank
ROA 13.72%
ROE 21.36%
ROCE 14.98%
ROIC 13.47%
ROICexc 13.47%
ROICexgc 14.99%
OM 26.86%
PM (TTM) 28.38%
GM 50.46%
FCFM N/A
ROA(3y)11.71%
ROA(5y)10.6%
ROE(3y)19.67%
ROE(5y)17.82%
ROIC(3y)11.43%
ROIC(5y)11.2%
ROICexc(3y)23.25%
ROICexc(5y)34.93%
ROICexgc(3y)26.06%
ROICexgc(5y)36.79%
ROCE(3y)12.71%
ROCE(5y)12.46%
ROICexgc growth 3Y-39.43%
ROICexgc growth 5Y-18.22%
ROICexc growth 3Y-41.68%
ROICexc growth 5Y-20%
OM growth 3Y-0.13%
OM growth 5Y9.82%
PM growth 3Y7.46%
PM growth 5Y11.08%
GM growth 3Y-0.69%
GM growth 5Y0.63%
F-ScoreN/A
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA 1.44
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.41
Quick Ratio 4.38
Altman-Z 13.33
F-ScoreN/A
WACC12.07%
ROIC/WACC1.12
Cap/Depr(3y)145.49%
Cap/Depr(5y)140.52%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.15%
Profit Quality(3y)82.13%
Profit Quality(5y)89.36%
High Growth Momentum
Growth
EPS 1Y (TTM)21.46%
EPS 3Y20.9%
EPS 5Y34.86%
EPS Q2Q%9.33%
EPS Next Y16.26%
EPS Next 2Y9.9%
EPS Next 3Y11.97%
EPS Next 5Y15.67%
Revenue 1Y (TTM)36.03%
Revenue growth 3Y16.74%
Revenue growth 5Y26.2%
Sales Q2Q%12.15%
Revenue Next Year15.95%
Revenue Next 2Y10.92%
Revenue Next 3Y12.13%
Revenue Next 5Y15.74%
EBIT growth 1Y48.56%
EBIT growth 3Y16.58%
EBIT growth 5Y38.59%
EBIT Next Year17.16%
EBIT Next 3Y15.19%
EBIT Next 5Y18.19%
FCF growth 1Y57.63%
FCF growth 3Y25.41%
FCF growth 5Y36.93%
OCF growth 1Y53.8%
OCF growth 3Y26.02%
OCF growth 5Y37.72%

CAMTEK LTD / CAMT FAQ

What is the fundamental rating for CAMT stock?

ChartMill assigns a fundamental rating of 6 / 10 to CAMT.


What is the valuation status of CAMTEK LTD (CAMT) stock?

ChartMill assigns a valuation rating of 2 / 10 to CAMTEK LTD (CAMT). This can be considered as Overvalued.


How profitable is CAMTEK LTD (CAMT) stock?

CAMTEK LTD (CAMT) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for CAMT stock?

The Price/Earnings (PE) ratio for CAMTEK LTD (CAMT) is 44.51 and the Price/Book (PB) ratio is 10.3.


What is the financial health of CAMTEK LTD (CAMT) stock?

The financial health rating of CAMTEK LTD (CAMT) is 5 / 10.